VIVO Meridian Bioscience Inc.

Meridian Improves Field-Testing in AgBio with its New Air-Dryable™ qPCR Mix for Crude Plant Samples

Meridian Improves Field-Testing in AgBio with its New Air-Dryable™ qPCR Mix for Crude Plant Samples

CINCINNATI, May 17, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today the launch of its new Air-Dryable™ Direct DNA qPCR Plant Mix. This unique Mix is specifically designed to develop and manufacture multiplexed highly sensitive and economical molecular field-tests in agriculture biotechnology (AgBio).

Increasing global food demand due to the growth in the human population accelerated the need for better crop health monitoring and surveillance. The requirements for constant monitoring of transgenic DNA from genetically modified organisms (GMO), coupled with the need for more reactive crop disease management with fast pathogen detection, led to the adoption of molecular techniques such as qPCR in agricultural diagnostics. While extraction of DNA from the plant sample before qPCR analysis does allow for the removal of various plant metabolites inhibiting the analysis, it is also a laborious and expensive activity. Meridian has developed an innovative solution for direct qPCR workflows using crude plant lysates without nucleic acid purification.

Meridian’s Air-Dryable™ Direct DNA qPCR Plant Mix uses a unique polymerase and buffer system, optimized explicitly for direct amplification from crude plant lysates – removing the need for purification of DNA from the sample. In addition, with its uniquely high 4x concentration format, the Air-Dryable™ Direct DNA qPCR Plant Mix facilitates the development of ambient temperature stable assays without the need for lyophilization – making it ideal for manufacturing field-friendly, highly sensitive, and cost-effective molecular plant assays.

Lourdes Weltzien, PhD, Executive Vice President – Life Science commented, “Air-dryable master mixes create a paradigm shift for molecular assay manufacturers. Room-temperature stable assays can now be created with an optimized master mix that can be oven-dried on site. Manufacturers can save time, reduce cost, and control their entire manufacturing workflow, while delivering the same or better performance as compared to other assay-formats. With the ability to use our Air-Dryable™ Direct DNA qPCR Plant Mix with crude samples, the testing process is faster and more economical than ever before.”

Meridian is committed to providing innovative solutions to diagnostic manufacturers that simplify and accelerate the development of superior assays. For more information about partnering with Meridian Bioscience, please visit or contact Morey Setareh, Senior Director, Sales & Marketing at .

About Meridian Bioscience, Inc.

Meridian is a fully integrated life science company that develops, manufactures, markets, and distributes a broad range of innovative diagnostic products. We are dedicated to developing and delivering better solutions that give answers with speed, accuracy, and simplicity that are redefining the possibilities of life from discovery to diagnosis. Through discovery and development, we provide critical life science raw materials used in immunological and molecular tests for human, animal, plant, and environmental applications. Through diagnosis, we provide diagnostic solutions in areas including gastrointestinal and upper respiratory infections and blood lead level testing. We build relationships and provide solutions to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices, diagnostics manufacturers, and biotech companies in more than 70 countries around the world.

Meridian’s shares are traded on the NASDAQ Global Select Market, symbol VIVO. Meridian’s website address is

Contact:

Charlie Wood

Vice President – Investor Relations

Meridian Bioscience, Inc.

Phone: +1 513.271.3700

Email:



EN
17/05/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Meridian Bioscience Inc.

 PRESS RELEASE

Meridian Launches Two New Air-Dryable qPCR Mixes Enabling Direct Detec...

Meridian Launches Two New Air-Dryable qPCR Mixes Enabling Direct Detection of DNA or RNA from Stool Samples CINCINNATI, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today the addition of two new Air-Dryable™ Master Mixes with the launch of its Air-Dryable™ Direct DNA qPCR Stool and Air-Dryable™ Direct RNA/DNA qPCR Stool Mixes. These innovative master mixes are designed to develop room-temperature stable molecular diagnostic assays that directly target nucleic acid sequences...

 PRESS RELEASE

Meridian Launches Two New Air-Dryable qPCR Mixes Enabling Direct Detec...

Meridian Launches Two New Air-Dryable qPCR Mixes Enabling Direct Detection of DNA or RNA from Saliva Samples CINCINNATI, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today the launch of its new Air-Dryable™ Direct DNA qPCR Saliva and Air-Dryable™ Direct RNA/DNA qPCR Saliva Mixes, which are designed for incorporation in room-temperature stable molecular assays, directly targeting nucleic acid sequence from saliva and sputum. Saliva is a complex fluid containing various enzy...

 PRESS RELEASE

Meridian Bioscience Reports Third Quarter Fiscal 2021 Results

Meridian Bioscience Reports Third Quarter Fiscal 2021 Results CINCINNATI, Aug. 06, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the third quarter ended June 30, 2021. Third Quarter 2021 Highlights (Comparison to Third Quarter Fiscal 2020):• Consolidated net revenues of $63.5 million, down 25% year-over-year, but up 31% from pre-pandemic third quarter fiscal 2019• Diagnostics segment net revenues increased 44% year-over-year to $31.2 million• Life Science segment net revenues decreased 49% year-over-year to $32.3 million• Re-Submi...

 PRESS RELEASE

Meridian Closes Acquisition of BreathTek® Business

Meridian Closes Acquisition of BreathTek® Business CINCINNATI, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today that it closed the previously announced acquisition of the North American BreathTek® business from Otsuka America Pharmaceutical, Inc. effective July 31, 2021. Information on the financial impacts to Meridian’s fiscal fourth quarter will be discussed on the quarterly earnings call scheduled for Friday, August 6, 2021. About Meridian Bioscience, Inc.Meridian is ...

 PRESS RELEASE

Meridian Signs Definitive Agreement to Acquire Urea Breath Test for H....

Meridian Signs Definitive Agreement to Acquire Urea Breath Test for H. pylori from Otsuka America Pharmaceutical, Inc. CINCINNATI, July 23, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today that it signed a definitive agreement to acquire the North American BreathTek® business from Otsuka America Pharmaceutical, Inc. for $20 million in cash. The transaction is expected to close in Meridian’s fiscal fourth quarter. With this acquisition, Meridian will assume the customer relationshi...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch